Rebecca Daniels Kush, Ph.D. is Founder, President and CEO of the Clinical Data Interchange Standards Consortium (CDISC), a non-profit standards developing organization (SDO) with a mission to develop and support global, platform-independent standards that enable information system interoperability to improve medical research and related areas of healthcare. Dr. Kush has over 25 years of experience in the area of clinical research, including positions with the U.S. National Institutes of Health, academia, a global CRO and pharmaceutical companies in the U.S. and Japan. She earned her doctorate in Physiology and Pharmacology from the University of California San Diego (UCSD) School of Medicine. She is lead author on the book: eClinical Trials: Planning and Implementation and has authored numerous publications for journals including New England Journal of Medicine and Science Translational Medicine. She has developed a Prescription Education Program for elementary and middle schools and was named in PharmaVoice in 2008 as one of the 100 most inspiring individuals in the life-sciences industry. Dr. Kush has served on the Board of Directors for the U.S. Health Information Technology Standards Panel (HITSP), DIA and currently Health Level 7 (HL7) and was a member of the advisory committee for the WHO International Clinical Trials Registry Platform.